Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy — Stella

Home/Tuberculosis Infection/Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

View on ClinicalTrials.gov

Recruiting

Back to Tuberculosis Infection trials

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Switzerland

Clinical Trial Center, Zurich

Key details

Phase

Early testing

Sponsor

University of Zurich

Enrollment target

~16 participants

Started

January 2022

Primary completion

October 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 50 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.